Hospitalisations | 178 (1 study) 12 months | ⊕⊖⊖⊖ VERY LOWa,b due to risk of bias, imprecision | rate ratio 1.23 (0.78 to 1.94) | 374 per 1000 | 86 more admissions per 1000 (from 82 fewer to 351 more) |
Death | 190 (1 study) 12 months | ⊕⊖⊖⊖ VERY LOWa,b due to risk of bias, imprecision | RR 1.07 (0.32 to 3.56) | 51 per 1000 | 4 more per 1000 (from 35 fewer to 131 more) |
Quality of life Kansas City Cardiomyopathy Questionnaire, final score. higher=better. Scale from: 0 to 100. | 180 (1 study) 12 months | ⊕⊖⊖⊖ VERY LOWa,b due to risk of bias, imprecision | | The KCCQ final score in the control groups was 66.3 | The mean KCCQ in the intervention groups was 1.70 higher (better) (3.28 lower to 6.68 higher) |
Quality of life (physical) SF-36 physical health composite, final score. higher=better. Scale from: 0 to 100. | 131 (1 study) 12 months | ⊕⊕⊖⊖ LOWa due to risk of bias | | The mean SF-physical in the control groups was 38.3 | The mean SF-physical in the intervention groups was 0.3 lower (worse) (3.25 lower to 2.65 higher) |
Quality of life (mental) SF-36 mental health composite, final score. higher=better. Scale from: 0 to 100. | 131 (1 study) 12 months | ⊕⊕⊖⊖ LOWa due to risk of bias | | The mean SF-mental in the control groups was 46.6 | The mean SF-mental in the intervention groups was 0.1 lower (worse) (3.5 lower to 3.5 higher) |
Prescribed double therapy of ACE-I/ARB and B-blocker | 180 (1 study) 12 months | ⊕⊕⊖⊖ LOWa due to risk of bias | RR 1.01 (0.84 to 1.2) | 720 ACE+BB per 1000 | 7 more ACE+BB per 1000 (from 115 fewer to 144 more) |